Biocon arm gets USFDA nod for cancer, deep vein thrombosis drugs Ruchika Sharma5 March 2025 11:30 AM ISTBangalore: Biocon Limited has announced that Biocon Pharma Limited, a wholly owned subsidiary of the Company, has received final approvals...
Alembic Pharma gets tentative USFDA nod for cancer drug Ivosidenib Ruchika Sharma5 July 2024 11:15 AM ISTVadodara: Alembic Pharmaceuticals Limited has announced that the Company has received tentative approval from the US Food & Drug...
Gilead Sciences pauses enrollment globally in magrolimab solid tumor studies Ruchika Sharma17 Feb 2024 2:43 PM ISTFoster City: Gilead Sciences, Inc. has announced that it has paused enrollment globally in the magrolimab solid tumor studies. The U.S. Food and Drug...
USFDA gives tentative nod to Biocon for cancer drug Dasatinib Ruchika Sharma7 Feb 2024 12:43 PM ISTBangalore: Biocon Limited has received tentative approval of its Abbreviated New Drug Application (ANDA) for Dasatinib tablets from the United...
Daiichi Sankyo Vanflyta approved in EU as First FLT3 Inhibitor specifically for newly Diagnosed FLT3-ITD Positive AML Ruchika Sharma13 Nov 2023 4:30 PM ISTTokyo: Daiichi Sankyo’s VANFLYTA (quizartinib) has been approved in the European Union (EU) for use in combination with standard cytarabine and ...
USFDA places partial clinical hold on Magrolimab studies in acute myeloid leukemia: Gilead Sciences Ruchika Sharma22 Aug 2023 12:30 PM ISTMagrolimab is a potential first-in-class investigational anti-CD47 immunotherapy.
